Grace Therapeutics, Inc. (GRCE) income statement
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
$1.71−0.02 (-1.16%)
Close on Nov 20, 2026Market cap $35.97MP/E –Yield –
Grace Therapeutics, Inc. financial ratios
See a number that looks wrong?